In other primary human RCC cells (RCC2 and RCC3), treatment with GNE-477 (50 nM) led to robust caspase-3 activation (Figure 2H) and nuclear TUNEL ratio increase (Figure 2I), indicating apoptosis activation. The gene discussed is CASP3; the disease is renal cell carcinoma.